Skip to main content

Advertisement

SpringerLink
Log in

Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription

  • Research Article
  • Published:
Tumor Biology

Abstract

Ki-67 as a cell proliferation marker is tightly associated with maintenance and regulation of the cell division. To understand the mechanism of Ki-67 gene expression and regulation, we first cloned 5′-flanking region and identified the Ki-67 core promoter. The deletion analysis and the dual luciferase reporter assay were used to locate the Ki-67 core promoter from −223 to +12 nt relative to the transcriptional initiation site, which is the TATA less, GC rich region comprised of several putative Sp1 binding sites. Compared with the hTERT promoter and Survivin promoter, the Ki-67 core promoter possessed higher transcription activity and more desirable tumor selectivity. In order to further demonstrate the contribution of transcription factor Sp1 on regulating the Ki-67 gene transcription, we confirmed three Sp1 binding sites from −170 to −145 nt, from −63 to −38 nt, and from −14 to +12 nt existed in the Ki-67 core promoter by the supershift assay. The deletion mutagenesis, together with the dual luciferase reporter assay, indicated that these Sp1 binding sites, particularly the region from −170 to −145 nt, were involved in positive regulation of the Ki-67 gene expression. Collectively, it was demonstrated that the region from −223 to +12 nt could drive the transcription of the Ki-67 gene, and the Sp1 binding site is essential to transcriptional regulation of the Ki-67 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Duchrow M, Schlueter C, Wohlenberg C, Flad HD, Gerdes J. Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67. Cell Prolif. 1996;29:1–12.

    Article  PubMed  CAS  Google Scholar 

  2. MacCallum DE, Hall PA. Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding. Exp Cell Res. 1999;252:186–98.

    Article  PubMed  CAS  Google Scholar 

  3. Scholzen T, Endl E, Wohlenberg C, van der Sar S, Cowell IG, Gerdes J, et al. The Ki-67 protein interacts with members of the heterochromatin protein 1(HP1) family: a potential role in the regulation of higher-order chromatin structure. J Pathol. 2002;196:135–44.

    Article  PubMed  CAS  Google Scholar 

  4. Bullwinkel J, Baron-Lühr B, Lüdemann A, Wohlenberg C, Gerdes J, Scholzen T. Ki-67 protein is associated with RNA transcription in quiescent and proliferating cells. J Cell Physiol. 2006;206:624–35.

    Article  PubMed  CAS  Google Scholar 

  5. MacCallum DE, Hall PA. The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J Pathol. 2000;190:537–44.

    Article  PubMed  CAS  Google Scholar 

  6. Rahmanzadeh R, Hüttmann G, Gerdes J, Scholzen T. Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif. 2007;40:422–30.

    Article  PubMed  CAS  Google Scholar 

  7. Fonatsch C, Duchrow G, Rieder H. Assignment of the human Ki67 gene (NKI67) to 10q25-qter. Genomics. 1991;11:467–77.

    Article  Google Scholar 

  8. Endl E, Gerdes J. Posttranslational modifications of the Ki-67 protein coincide with two major checkpoints during mitosis. J Cell Physiol. 2000;182:371–80.

    Article  PubMed  CAS  Google Scholar 

  9. Kausch I, Lingnau A, Endl E, Sellmann K, Deinert I, Ratliff TL, et al. Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo. Int J Cancer. 2003;105:710–6.

    Article  PubMed  CAS  Google Scholar 

  10. Safe S, Kim K. Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Re. 2004;77:1–36.

    Article  CAS  Google Scholar 

  11. Mounier C, Posner BI. Transcriptional regulation by insulin: from the receptor to the gene. Can J Physiol Pharmacol. 2006;84:713–24.

    Article  PubMed  CAS  Google Scholar 

  12. Lee TH, Chang HC, Chuang LY, Hung WC. Involvement of PKA and Sp1 in the induction of p27(Kip) by tamoxifen. Biochem Pharmacol. 2003;66:371–7.

    Article  PubMed  CAS  Google Scholar 

  13. Solomon SS, Majumdar G, Martinez-Hernandez A, Raghow R. A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. Life Sci. 2008;83:305–12.

    Article  PubMed  CAS  Google Scholar 

  14. Hwang CK, D’Souza UM, Eisch AJ, Yajima S, Lammers CH, Yang Y, Lee SH, Kim YM, Nestler EJ, Mouradian MM. Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor. Proc Natl Acad Sci U S A.; 98:7558–7563.

  15. Schlüter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol. 1993;123:513–22.

    Article  PubMed  Google Scholar 

  16. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311–22.

    Article  PubMed  CAS  Google Scholar 

  17. Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer. 2005;41:2438–48.

    Article  PubMed  CAS  Google Scholar 

  18. Taguchi A, White MF. Insulin-like signaling, nutrient homeostasis and life span. Annu Rev Physiol. 2008;70:191–212.

    Article  PubMed  CAS  Google Scholar 

  19. Geng Y, Tsai-Morris CH, Zhang Y, Dufau ML. The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation. Biochem Bioph Res Co. 1999;263:366–71.

    Article  CAS  Google Scholar 

  20. Goldberg HJ, Whiteside CI, Hart GW, Fantus IG. Posttranslational, reversible Ois stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology. 2006;147:222–31.

    Article  PubMed  CAS  Google Scholar 

  21. Liu WL, Coleman RA, Grob P, King DS, Florens L, Washburn MP, et al. Structural changes in TAF4b-TFIID correlate with promoter selectivity. Mol Cell. 2008;29:81–91.

    Article  PubMed  Google Scholar 

  22. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol. 2002;195:27–38.

    Article  PubMed  CAS  Google Scholar 

  23. Wade PA. Methyl CpG-binding proteins and transcriptional repression. BioEssays. 2007;23:1131–7.

    Article  Google Scholar 

  24. Lee TF, Zhai J, Meyers BC. Conservation and divergence in eukaryotic DNA methylation. Proc Natl Acad Sci U S A. 2010;107:9027–8.

    Article  PubMed  CAS  Google Scholar 

  25. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, et al. Sp1 elements protect a CpG island from de novo methylation. Nature. 1994;371:435–8.

    Article  PubMed  CAS  Google Scholar 

  26. Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 1994;8:2282–92.

    Article  PubMed  CAS  Google Scholar 

  27. Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, et al. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol. 2003;23:4056–65.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This project is supported by grants from the National Natural Science Foundation of China (No. 30972976 and 81071854), the Program for New Century Excellent Talents in University (NCET-08-0700), and the Science and Technology Department of Jiangsu Province (No. BK2009089, BK2009091, and BK2010177).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, 84 West Huai-hai Road, Xuzhou, 221002, China

    Dong-Sheng Pei, Guo-Wei Qian, Hui Tian, Wang Li & Jun-Nian Zheng

  2. Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical College, Xuzhou, 221002, China

    Jun-Nian Zheng

  3. School of Pharmacy, Xuzhou Medical College, Xuzhou, China

    Jie Mou

Authors
  1. Dong-Sheng Pei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guo-Wei Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hui Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jie Mou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun-Nian Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun-Nian Zheng.

Additional information

Dong-Sheng Pei and Guo-Wei Qian contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pei, DS., Qian, GW., Tian, H. et al. Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription. Tumor Biol. 33, 257–266 (2012). https://doi.org/10.1007/s13277-011-0277-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-011-0277-z

Keywords

Search

Navigation